PD-L1 and lung cancer: The era of precision-ish medicine?

Keyphrases

• Immunohistochemistry 100%
• Lung Cancer 100%
• Programmed Death-ligand 1 (PD-L1) 100%
• Drug Development 50%
• Pathologist 50%
• Molecular Targets 50%
• Oncologists 50%
• Molecular Diagnostics 50%
• Targeted Therapy 50%
• Cancer Therapy 50%
• Small Cell Carcinoma 50%
• U.S. Food 50%
• Looming 50%
• Oncogenic mutations 50%
• Intense Interests 50%
• Precision Medicine 50%
• Non-squamous 50%
• Complementary Diagnostic Test 50%
• Companion Diagnostics 50%
• Prescribing Information 50%
• Immune Checkpoint Inhibitor Therapy 50%
• Emerging Challenges 50%

Medicine and Dentistry

• Medicine 100%
• Lung Cancer 100%
• Immunohistochemistry 100%
• Programmed Death 1 Ligand 1 100%
• Cancer Therapy 50%
• Oncologist 50%
• Diagnosis 50%
• Drug Therapy 50%
• Pathologist 50%
• Targeted Therapy 50%
• Personalized Medicine 50%
• Diagnostic Test 50%
• Small-Cell Carcinoma 50%
• Immune Checkpoint Inhibitor 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Cancer 100%
• Programmed Death 1 Ligand 1 100%
• Malignant Neoplasm 50%
• Drug Development 50%
• Molecular Target 50%
• Small Cell Carcinoma 50%
• Immune Checkpoint Inhibitor 50%